GTR 107745626
Tenders Are Invited For A Atezolizumab (Genetical Recombination) (1,20020Ml/Vial) 190Vials, Emicizumab (Genetical Recombination) (900.6MlVial) 60Vials, Emicizumab (Genetical Recombination) (1050.7MlVial) 90Vials
ICB — International Competitive Bid
Closed
Asia
Tender Information
GTR Reference
107745626
Tendering Authority
Subscribe to view
Tender No
379619
Financer Name
Self-Funded
Work Title
Tenders Are Invited For A Atezolizumab (Genetical Recombination) (1,20020Ml/Vial) 190Vials, Emicizumab (Genetical Recombination) (900.6MlVial) 60Vials, Emicizumab (Genetical Recombination) (1050.7MlVial) 90Vials
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
Asia-Pacific Economic Cooperation, APEC,G20,APAC (Asia Pacific)
Last Date of Bid Submission
13-03-2026
Closed
Work Detail
A Atezolizumab (Genetical Recombination) (1,20020Ml/Vial) 190Vials, Emicizumab (Genetical Recombination) (900.6MlVial) 60Vials, Emicizumab (Genetical Recombination) (1050.7MlVial) 90Vials
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
6949ae90-8709-4994-b4de-1c6013c03343.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.